Company becomes preferred manufacturing partner for Brazilian and international pharmaceutical companies launching or expanding in Latin America’s largest healthcare market

Benuvia Operations, LLC, a global contract development and manufacturing organization, today announced that it has received a Good Manufacturing Practices (GMP) certification (Certificado de Boas Práticas de Fabricação or CBPF) from Brazil’s National Health Surveillance Agency (ANVISA).

“Achieving ANVISA’s CBPF certification underscores Benuvia’s strategic commitment to providing high-quality, compliant pharmaceutical manufacturing specifically tailored to Brazil’s rapidly growing healthcare market. I’m incredibly proud of our team’s exceptional dedication and hard work in meeting ANVISA’s stringent standards, positioning us as a trusted manufacturing partner for pharmaceutical companies in Brazil,” stated Terry Novak, CEO of Benuvia.

Health Technology Insights: HealthArc Revolutionizes Remote Healthcare with AI and Analytics

ANVISA’s CBPF certification is an essential regulatory prerequisite for pharmaceutical companies to manufacture and distribute pharmaceutical products within Brazil, the largest healthcare market in Latin America. Companies that receive ANVISA CBPF certification are required to meet rigorous local manufacturing standards. This certification enables Benuvia to produce non-sterile liquid pharmaceutical products for local and international pharmaceutical companies seeking compliant and high-quality production capabilities within the Brazilian pharmaceutical market.

Health Technology Insights: ABBYY Opens AI Labs to Enhance Document AI for Automation

Mr. Novak continued, “ANVISA CBPF certification allows us to be the preferred provider for companies seeking a partner with quicker market entry, reduced regulatory hurdles, and stronger credibility among regulatory bodies, healthcare providers, and pharmaceutical customers.”

Health Technology Insights: August Health and Kevala Partner for Real-Time Senior Care Insights

To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com

Source – PR Newswire